glenmark
-
Glenmark partners with Pfizer to launch atopic dermatitis drug Abrocitinib in India
Glenmark and Pfizer will co‐market abrocitinib in India under the brand names JABRYUS and CIBINQO Pfizer and Glenmark Pharmaceuticals have…
Read More » -
Glenmark launches biosimilar of anti-diabetic drug Liraglutide in India
The drug is being marketed under the brand name Lirafit following the approval from the Drug Controller General of India…
Read More » -
Cosmo, Glenmark sign distribution and license agreements for Winlevi in Europe and South Africa
Under the terms of the agreements, Glenmark will receive from Cassiopea, a subsidiary of Cosmo, the exclusive right to commercialise…
Read More » -
Glenmark launches Lobeglitazone for Type 2 diabetes in India
The drug has to be taken once daily under prescription to improve glycemic control in adult diabetic patients Glenmark Pharmaceuticals…
Read More » -
Glenmark Specialty bags DCGI approval for Phase 1 trial novel molecule GRC 54276
Glenmark will initiate a Phase 1 clinical trial by June 2022 to determine the safety, tolerability, and preliminary anti-tumour activity…
Read More » -
Glenmark to divest select anti-allergy brands to Dr Reddy’s
The company will divest in Russia Ukraine Kazakhstan and Uzbekistan in anticipation of its ‘Ryaltris’ launch Glenmark Pharmaceuticals has entered…
Read More » -
Glenmark initiates Phase 3 clinical trials on antiviral Favipiravir for COVID-19 patients in India
Mumbai: Glenmark Pharmaceuticals, has initiated Phase 3 clinical trials in India on Antiviral tablet Favipiravir, for which it received approval…
Read More » -
Glenmark to spin off its innovation business into a new company in the US
Glenmark Pharmaceuticals, today announced that its Board of Directors has given an in-principle approval to spin off the innovation business…
Read More »